255 related articles for article (PubMed ID: 23892139)
1. Effects of bisphosphonate treatment on DNA methylation in osteonecrosis of the jaw.
Polidoro S; Broccoletti R; Campanella G; Di Gaetano C; Menegatti E; Scoletta M; Lerda E; Matullo G; Vineis P; Berardi D; Scully C; Arduino PG
Mutat Res; 2013 Oct; 757(2):104-13. PubMed ID: 23892139
[TBL] [Abstract][Full Text] [Related]
2. Osteonecrosis of the jaws in patients assuming oral bisphosphonates for osteoporosis: a retrospective multi-hospital-based study of 87 Italian cases.
Di Fede O; Fusco V; Matranga D; Solazzo L; Gabriele M; Gaeta GM; Favia G; Sprini D; Peluso F; Colella G; Vescovi P; Campisi G
Eur J Intern Med; 2013 Dec; 24(8):784-90. PubMed ID: 23768563
[TBL] [Abstract][Full Text] [Related]
3. The role of surgical resection in the management of bisphosphonate-related osteonecrosis of the jaws.
Carlson ER; Basile JD
J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):85-95. PubMed ID: 19371819
[TBL] [Abstract][Full Text] [Related]
4. Effect of antiresorptive drugs on bony turnover in the jaw: denosumab compared with bisphosphonates.
Ristow O; Gerngroß C; Schwaiger M; Hohlweg-Majert B; Kehl V; Jansen H; Hahnefeld L; Koerdt S; Otto S; Pautke C
Br J Oral Maxillofac Surg; 2014 Apr; 52(4):308-13. PubMed ID: 24582013
[TBL] [Abstract][Full Text] [Related]
5. [Clinical features of osteonecrosis of jaws after bisphosphonates therapy for bone metastasis of breast cancer].
Guo YX; Wang DC; Wang Y; Peng X; Mao C; Guo CB
Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Feb; 48(1):80-3. PubMed ID: 26885913
[TBL] [Abstract][Full Text] [Related]
6. Is bone turnover of jawbone and its possible over suppression by bisphosphonates of etiologic importance in pathogenesis of bisphosphonate-related osteonecrosis?
Ristow O; Gerngroß C; Schwaiger M; Hohlweg-Majert B; Kehl V; Jansen H; Hahnefeld L; Otto S; Pautke C
J Oral Maxillofac Surg; 2014 May; 72(5):903-10. PubMed ID: 24485975
[TBL] [Abstract][Full Text] [Related]
7. Ninety-one osteoporosis patients affected with bisphosphonate-related osteonecrosis of the jaw: a case series.
Mercer E; Norton T; Woo S; Treister N; Dodson TB; Solomon DH
Calcif Tissue Int; 2013 Sep; 93(3):241-8. PubMed ID: 23756612
[TBL] [Abstract][Full Text] [Related]
8. Establishment of an Animal Model of Bisphosphonate-Related Osteonecrosis of the Jaws in Spontaneously Diabetic Torii Rats.
Takaoka K; Yamamura M; Nishioka T; Abe T; Tamaoka J; Segawa E; Shinohara M; Ueda H; Kishimoto H; Urade M
PLoS One; 2015; 10(12):e0144355. PubMed ID: 26659123
[TBL] [Abstract][Full Text] [Related]
9. Epidemiology, pharmacology and clinical characterization of bisphosphonate-related osteonecrosis of the jaw. A retrospective study of 70 cases.
Pelaz A; Junquera L; Gallego L; García-Consuegra L; García-Martínez L; Cutilli T; Olay S
Acta Otorrinolaringol Esp; 2015; 66(3):139-47. PubMed ID: 25308796
[TBL] [Abstract][Full Text] [Related]
10. Zoledronate and osteonecrosis of the jaw in osteoporosis: incidence and risk factors. Analysis of the French Pharmacovigilance Database.
Amigues C; Fresse A; Roux CH; Gauthier S; Vieillard MH; Drici MD; Breuil V;
Joint Bone Spine; 2023 Dec; 90(6):105599. PubMed ID: 37271278
[TBL] [Abstract][Full Text] [Related]
11. Bone scintigraphy predicts bisphosphonate-induced osteonecrosis of the jaw (BRONJ) in patients with metastatic castration-resistant prostate cancer (mCRPC).
Thomas C; Spanidis M; Engel C; Roos FC; Frees S; Neisius A; Hampel C; Rubenwolf P; Thüroff JW; Walter C; Miederer M
Clin Oral Investig; 2016 May; 20(4):753-8. PubMed ID: 26307268
[TBL] [Abstract][Full Text] [Related]
12. Quantification by energy dispersive x-ray spectroscopy of alendronate in the diseased jaw bone of patients with bisphosphonate-related jaw osteonecrosis.
Schaudinn C; Gorur A; Webster P; Jones AC; Neely M; Jelliffe RW; Le AD; Sedghizadeh PP
Oral Surg Oral Med Oral Pathol Oral Radiol; 2012 Oct; 114(4):480-6. PubMed ID: 22986243
[TBL] [Abstract][Full Text] [Related]
13. Database analysis of the risk factors of bisphosphonate-related osteonecrosis of the jaw in Hungarian patients.
Veszelyné Kotán E; Bartha-Lieb T; Parisek Z; Meskó A; Vaszilkó M; Hankó B
BMJ Open; 2019 May; 9(5):e025600. PubMed ID: 31122970
[TBL] [Abstract][Full Text] [Related]
14. Preexisting Periapical Inflammatory Condition Exacerbates Tooth Extraction-induced Bisphosphonate-related Osteonecrosis of the Jaw Lesions in Mice.
Song M; Alshaikh A; Kim T; Kim S; Dang M; Mehrazarin S; Shin KH; Kang M; Park NH; Kim RH
J Endod; 2016 Nov; 42(11):1641-1646. PubMed ID: 27637460
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the prognosis of bisphosphonate-related osteonecrosis of the jaw caused by oral and intravenous bisphosphonates.
Shintani T; Hayashido Y; Mukasa H; Akagi E; Hoshino M; Ishida Y; Hamana T; Okamoto K; Kanda T; Koizumi K; Yoshioka Y; Tani R; Toratani S; Okamoto T
Int J Oral Maxillofac Surg; 2015 Jul; 44(7):840-4. PubMed ID: 25861974
[TBL] [Abstract][Full Text] [Related]
16. Does regular zoledronic acid change the bone turnover of the jaw in men with metastatic prostate cancer: a possible clue to the pathogenesis of bisphosphonate related osteonecrosis of the jaw?
Ristow O; Gerngroß C; Schwaiger M; Hohlweg-Majert B; Ristow M; Koerdt S; Schuster R; Otto S; Pautke C
J Cancer Res Clin Oncol; 2014 Mar; 140(3):487-93. PubMed ID: 24469255
[TBL] [Abstract][Full Text] [Related]
17. Multipotent mesenchymal stromal cell sheet therapy for bisphosphonate-related osteonecrosis of the jaw in a rat model.
Kaibuchi N; Iwata T; Yamato M; Okano T; Ando T
Acta Biomater; 2016 Sep; 42():400-410. PubMed ID: 27326918
[TBL] [Abstract][Full Text] [Related]
18. Incidence of bisphosphonate-related osteonecrosis of the jaw in consideration of primary diseases and concomitant therapies.
Assaf AT; Smeets R; Riecke B; Weise E; Gröbe A; Blessmann M; Steiner T; Wikner J; Friedrich RE; Heiland M; Hoelzle F; Gerhards F
Anticancer Res; 2013 Sep; 33(9):3917-24. PubMed ID: 24023329
[TBL] [Abstract][Full Text] [Related]
19. Quantitative ultrasound at the hand phalanges in patients with bisphosphonate-related osteonecrosis of the jaws.
Motta AC; de Macedo LD; Santos GG; Guerreiro CT; Ferrari T; de Oliveira TF; Santos PS; de Oliveira-Santos C; Ricz HM; Xavier SP; Iannetta O
Braz Oral Res; 2015; 29(1):S1806-83242015000100301. PubMed ID: 26892357
[TBL] [Abstract][Full Text] [Related]
20. Osteonecrosis of the jaw and nonmalignant disease: is there an association with rheumatoid arthritis?
Lescaille G; Coudert AE; Baaroun V; Javelot MJ; Cohen-Solal M; Berdal A; Goudot P; Azérad J; Ruhin B; Descroix V
J Rheumatol; 2013 Jun; 40(6):781-6. PubMed ID: 23504384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
